The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

A renowned virologist and former vice-chancellor of Redeemer’s University, Prof. Oyewale Tomori, has warned that Lassa fever ...

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

The country is presently battling its eighth Ebola outbreak, confirmed by the Ministry of Health in January, with two ...

New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

Rarely if ever does a newspaper headline include the words “crisis averted,” yet, that is what investments in development ...

Hantavirus? You must have read about the wife of a famous celebrity whose death was attributed to the virus. Albeit rare, it ...

The Nigeria Centre for Disease Control and Prevention (NCDC) has reported a decline in new confirmed Lassa fever cases across ...

A (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.